跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VISIPAQUE iodixanol 32.6g/50mL (652mg/mL) injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
VISIPAQUE iodixanol 32.6g/50mL (652mg/mL) injection ampoule
Approved
STANDARD
VISIPAQUE iodixanol 32.6g/50mL (652mg/mL) injection ampoule
GE Healthcare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
7e7845e4dac757e6
Company
GE Healthcare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7e7845e4dac757e6
Product Name
VISIPAQUE iodixanol 32.6g/50mL (652mg/mL) injection ampoule
Artg Id
75926
Artg Name
VISIPAQUE iodixanol 32.6g/50mL (652mg/mL) injection ampoule
Sponsor
GE Healthcare Australia Pty Ltd
Company Detail Path
/organization/ge-healthcare-australia-pty-limited
Artg Date
2000-11-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8996125ee0e4e913b4b34a68b43d8642.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/ac8d1dc4da3e22fafe78e2386fb7fdc1.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
7e7845e4dac757e6
Type
Standard
Back to TGA Approvals